Evidence map›Paper›PMID 36008787›Full record

ArticleBMC public health2022

Access, utilization, and barriers to using malaria protection tools in migrants to Iran.

Hassan Okati-Aliabad, Alireza Ansari-Moghaddam, Mahdi Mohammadi, Jalil Nejati, Mansour Ranjbar, Ahmad Raeisi, Goodarz Kolifarhood, Fariba Shahraki-Sanavi, Alireza Khorram

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Epidemiology of malaria in saravan city and its suburbs from 2018 to 2023, Southeast Iran.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hassan Okati-AliabadHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Alireza Ansari-MoghaddamHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Mahdi MohammadiHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Jalil NejatiHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. jalilnejati@yahoo.com.
Mansour RanjbarHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Ahmad RaeisiNational Program for Malaria Control, Center of Disease Control & Prevention, Ministry of Health and Medical Education, Tehran, Iran.
Goodarz KolifarhoodNational Program for Malaria Control, Center of Disease Control & Prevention, Ministry of Health and Medical Education, Tehran, Iran.
Fariba Shahraki-SanaviHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Alireza KhorramHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Zahedan University of Medical Sciences · IRMinistry of Health and Medical Education · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImported malaria cases could be considered one of the threats to malaria elimination. Therefore, increasing migrants' access to malaria preventive measures can play an essential role in maintaining appropriate conditions and preventing malaria outbreaks. This study aimed to provide detailed information about access, utilization, and barriers to using malaria protection tools in migrants to Iran.

methodsThis study was conducted in a vast region consisting of 4 provinces and 38 cities located in the south and southeast of the country. Study participants were migrants who moved to the study area in the past three months. A sample of 4163 migrants participated in the study. They were selected through a multi-stage sampling method to obtain a representative community sample. Data were collected through interviewer-administered questionnaires about participants' socio-demographic specification, commuting characteristics, travel aim, access, ways of preparing, and reasons to use or not to use malaria protection tools. Quantitative and qualitative variables were described and analyzed finally.

resultsThe mean age of individuals was 28.6 ± 10.8, with a range of 3-88 years old. Migrants' country of origin was Afghanistan (56.6%), Pakistan (38.4%), and Iran (5%). Most migrants (69.2%) did not have malaria protection tools while staying in Iran. Among those who procured the protection tools, 74% used long-lasting insecticidal nets (LLINs), 13.4% used mosquito repellent sticks and coil, and 12.7% did not use any tools. Respectively, lack of knowledge about where they can get LLINs, followed by being expensive, unavailability in the market, not cooperation of health officer, and no need to use were expressed as the causes for having no access. The main reasons for non-using the tools were lack of knowledge about their application, followed by a defect in protection tools, ineffectiveness, and being harmful, respectively. Migrants who were supported by an employer accessed more to LLINs.

conclusionsThis study reveals significant shortcomings in knowledge, access, and utilization of malaria protection tools among migrants in Iran. Inequitable access to public health services is predictable during migration; however, access to sustainable protection tools is recommended.

Indexed as

InsecticidesInsecticide-Treated BednetsMalariaTransients and MigrantsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolHumansIranMiddle AgedMosquito ControlSurveys and QuestionnairesYoung AdultInsecticidesIranMalariaMigrantsProtection

Identifiers

PMID36008787
PMCPMC9404647
OpenAlexW4293089489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.